These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28681249)

  • 1. A systematic review of the barriers affecting medication adherence in patients with rheumatic diseases.
    Goh H; Kwan YH; Seah Y; Low LL; Fong W; Thumboo J
    Rheumatol Int; 2017 Oct; 37(10):1619-1628. PubMed ID: 28681249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol.
    Kelly A; Tong A; Tymms K; March L; Craig JC; De Vera M; Evans V; Hassett G; Toupin-April K; van den Bemt B; Teixeira-Pinto A; Alten R; Bartlett SJ; Campbell W; Dawson T; Gill M; Hebing R; Meara A; Nieuwlaat R; Shaw Y; Singh JA; Suarez-Almazor M; Sumpton D; Wong P; Christensen R; Beaton D; de Wit M; Tugwell P;
    Trials; 2018 Mar; 19(1):204. PubMed ID: 29587864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What are the effects of medication adherence interventions in rheumatic diseases: a systematic review.
    Galo JS; Mehat P; Rai SK; Avina-Zubieta A; De Vera MA
    Ann Rheum Dis; 2016 Apr; 75(4):667-73. PubMed ID: 25667208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication adherence of patients with selected rheumatic conditions: a systematic review of the literature.
    Harrold LR; Andrade SE
    Semin Arthritis Rheum; 2009 Apr; 38(5):396-402. PubMed ID: 18336875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of rheumatology-specific patient navigators to understand and reduce barriers to medication adherence: Analysis of qualitative findings.
    Wohlfahrt A; Campos A; Iversen MD; Gagne JJ; Massarotti E; Solomon DH; Feldman CH
    PLoS One; 2018; 13(7):e0200886. PubMed ID: 30024938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of the barriers affecting medication adherence in older adults.
    Yap AF; Thirumoorthy T; Kwan YH
    Geriatr Gerontol Int; 2016 Oct; 16(10):1093-1101. PubMed ID: 26482548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of factors affecting medication adherence among patients with osteoporosis.
    Yeam CT; Chia S; Tan HCC; Kwan YH; Fong W; Seng JJB
    Osteoporos Int; 2018 Dec; 29(12):2623-2637. PubMed ID: 30417253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the COVID-19 Pandemic on Medical Management and on Healthcare Delivery of Immune-Mediated Rheumatic and Musculoskeletal Diseases during the First Pandemic Period February to July 2020: A Systematic Review.
    Schlegel M; Bachmann S
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Adaptable Framework for Factors Contributing to Medication Adherence: Results from a Systematic Review of 102 Conceptual Frameworks.
    Peh KQE; Kwan YH; Goh H; Ramchandani H; Phang JK; Lim ZY; Loh DHF; Østbye T; Blalock DV; Yoon S; Bosworth HB; Low LL; Thumboo J
    J Gen Intern Med; 2021 Sep; 36(9):2784-2795. PubMed ID: 33660211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting medication adherence among pre-dialysis chronic kidney disease patients: a systematic review and meta-analysis of literature.
    Seng JJB; Tan JY; Yeam CT; Htay H; Foo WYM
    Int Urol Nephrol; 2020 May; 52(5):903-916. PubMed ID: 32236780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing Challenges in Developing a Core Domain Set in Adherence Interventions in Rheumatology: A Report from the OMERACT-Adherence Group.
    Kelly A; Bartlett SJ; de Wit MP; Beaton DE; Dawson T; Evans V; Gill M; Hassett G; March L; Scholte-Voshaar M; Singh JA; Tong A; Tugwell P; Wong P; Tymms K
    J Rheumatol; 2019 Sep; 46(9):1202-1206. PubMed ID: 30647162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adherence questionnaires in chronic inflammatory rheumatic diseases and their psychometric properties: A systematic literature review.
    Rakotozafiarison A; Puyraimond-Zemmour D; Romand X; Lavielle M; Moltó A; Flipo RM; Richez C; Saraux A; Dougados M; Gossec L
    Joint Bone Spine; 2021 May; 88(3):105160. PubMed ID: 33578034
    [No Abstract]   [Full Text] [Related]  

  • 13. A systematic review of factors that influence treatment adherence in paediatric oncology patients.
    Goh XT; Tan YB; Thirumoorthy T; Kwan YH
    J Clin Pharm Ther; 2017 Feb; 42(1):1-7. PubMed ID: 28045208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Traditional Chinese Medicine Use With Adherence to Prescribed Western Rheumatic Medications Among Chinese American Patients: A Cross-Sectional Survey.
    Sun K; Szymonifka J; Tian H; Chang Y; Leng JC; Mandl LA
    Arthritis Care Res (Hoboken); 2020 Oct; 72(10):1474-1480. PubMed ID: 31325227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scope of Outcomes in Trials and Observational Studies of Interventions Targeting Medication Adherence in Rheumatic Conditions: A Systematic Review.
    Kelly A; Crimston-Smith L; Tong A; Bartlett SJ; Bekker CL; Christensen R; De Vera MA; de Wit M; Evans V; Gill M; March L; Manera K; Nieuwlaat R; Salmasi S; Scholte-Voshaar M; Singh JA; Sumpton D; Toupin-April K; Tugwell P; van den Bemt B; Verstappen S; Tymms K
    J Rheumatol; 2020 Oct; 47(10):1565-1574. PubMed ID: 31839595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for the assessment and optimization of adherence to disease-modifying drugs in chronic inflammatory rheumatic diseases: A process based on literature reviews and expert consensus.
    Gossec L; Molto A; Romand X; Puyraimond-Zemmour D; Lavielle M; Beauvais C; Senbel E; Flipo RM; Pouplin S; Richez C; Saraux A; Mézières M; Gutermann L; Gaudin P; Wendling D; Dougados M
    Joint Bone Spine; 2019 Jan; 86(1):13-19. PubMed ID: 30243782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the French version of the Compliance Questionnaire for Rheumatology (CQR-5), a self-reporting questionnaire specific to patients with chronic inflammatory rheumatic disease.
    Cavagna P; Hubert J; Bottois C; Lopez-Medina C; Roux C; Conort O; Dougados M
    Joint Bone Spine; 2022 Nov; 89(6):105449. PubMed ID: 35944599
    [No Abstract]   [Full Text] [Related]  

  • 18. Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology: A report from the OMERACT-Adherence Group.
    Kordkheili AM; Bekker C; Hoens AM; Voshaar M; Campbell W; Carmona L; de Wit M; March L; Nielsen SM; Shea BJ; Toupin-April K; Tugwell P; Tymms K; Kelly A;
    Semin Arthritis Rheum; 2024 Jun; 66():152411. PubMed ID: 38537323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
    Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
    JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers and facilitators to disease-modifying antirheumatic drug use in patients with inflammatory rheumatic diseases: a qualitative theory-based study.
    Voshaar M; Vriezekolk J; van Dulmen S; van den Bemt B; van de Laar M
    BMC Musculoskelet Disord; 2016 Oct; 17(1):442. PubMed ID: 27769224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.